Aplio i900 vs Tempus ECG-Low EF
AI Verdict
Choose Aplio i900 if…
Choose the Aplio i900 if your clinical setting requires a premium, on-premise cardiovascular ultrasound system for comprehensive, real-time diagnostic imaging. This tool is ideal for advanced 4D imaging, precise automated analysis of cardiac function, and detailed assessment of complex cardiovascular conditions, making it suitable for specialized cardiology departments needing high-fidelity visualization and in-depth quantitative measurements.
View Aplio i900 →Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if you need an AI-powered software solution to quickly screen and identify patients at risk for low left ventricular ejection fraction from standard 12-lead ECGs. This tool is optimal for integrating into existing healthcare facility workflows to aid in early detection and further evaluation of heart failure risk in patients 40 years or older, serving as an efficient initial screening tool.
View Tempus ECG-Low EF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Aplio i900 | Tempus ECG-Low EF |
|---|---|---|
| Pricing | Varies | Unknown |
| Deployment | Mobile, compact diagnostic ultrasound system | Integrates with current ECG platforms and electronic health records (EHRs). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Aplio i900Tool A emphasizes intuitive ergonomics with touch-control screens and automated image adjustments, directly enhancing the sonographer's hands-on experience and efficiency in performing complex imaging tasks. While Tool B focuses on seamless integration into existing workflows and simple output, Tool A's features are specifically designed to make direct user interaction with the device simpler and quicker.
Clinical Value
Aplio i900Tool A offers comprehensive, high-resolution diagnostic imaging and advanced quantitative analysis for a broad spectrum of cardiovascular conditions, enabling definitive diagnoses and procedural guidance. In contrast, Tool B provides a targeted screening tool for early identification of low LVEF, which, while valuable, is intended to prompt further evaluation rather than provide a definitive diagnosis.
Pricing & Value
TieBoth tools require contacting the vendor for pricing, and specific cost details are not publicly available. Without transparent pricing or detailed comparative ROI studies, it is impossible to objectively assess and compare their value propositions.
Enterprise Readiness
Tempus ECG-Low EFWhile both are FDA-cleared and HIPAA compliant, Tool B, as a software solution, explicitly states it has a Business Associate Agreement (BAA) and is designed for integration into healthcare facility workflows and EHR systems. This focus on software integration and data privacy agreements makes it highly adaptable for broad enterprise-wide deployment.
Innovation
Tempus ECG-Low EFTool B demonstrates a more disruptive innovation by applying AI to a common, low-cost ECG to identify a specific, high-risk condition (low LVEF), creating a new, scalable screening pathway for early detection in a broad patient population. Tool A, while highly advanced, primarily innovates by enhancing an existing high-end diagnostic modality with AI for superior imaging and analysis.
Support & Docs
TieThe provided information and web searches indicate that both companies offer standard support channels and documentation typical for their respective product types (medical device vs. software). However, there is insufficient specific detail to definitively distinguish between the quality, comprehensiveness, or responsiveness of their support and documentation offerings.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Aplio i900 | Tempus ECG-Low EF |
|---|---|---|
| Name | Aplio i900 | Tempus ECG-Low EF |
| Company | Canon Medical Systems Corporation | Tempus AI |
| Description | The Aplio i900 is a premium cardiovascular diagnostic ultrasound system by Canon Medical Systems, featuring advanced 4D imaging, AI-powered image enhancement, and automated analysis tools for precise and efficient cardiac diagnostics. | Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF ≤40%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. |
| Key Features | Premium Cardiovascular Ultrasound System, Advanced 4D Imaging (e.g., 4D TEE, MVA), Automated Analysis & Measurement Tools (EF, GLS, MPI, 3D Wall Motion Tracking), iPerformance (Extreme Processing Power), iSense & Touch-control Screens for Intuitive Ergonomics, Real-time Quick Scan for Automatic Image Adjustments, 3rd Harmonic Imaging (3-HI) with Deep Learning AI, SMI Angio (Superb Micro-vascular Imaging) for Microvascular Flow | AI-powered algorithm for ECG analysis, Detects signs of low Left Ventricular Ejection Fraction (LVEF ≤40%), Analyzes resting, non-ambulatory 12-lead ECG recordings, Provides a binary output (Low LVEF Detected / Not Detected), Aids in identifying patients 40+ years at risk of heart failure, Trained on a large dataset of over 930,000 ECGs from 170,000+ patients, Intended for use in clinical diagnostic settings at healthcare facilities |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Aplio i900 and Tempus ECG-Low EF.
More Comparisons
More matchups featuring Aplio i900 or Tempus ECG-Low EF
Backers
Who funded each tool's parent company.